Bgm BGM
NASDAQ BGM
$0.26 -0.02 (-7.52%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bgm (BGM) Cash & Equivalents Growth (3y) (2022 - 2025)

Bgm (BGM) Cash & Equivalents Growth (3y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 21.81%
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 11.05%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -4.92%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 7.80%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 19.10%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 12.11%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 27.55%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 13.03%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 32.82%
10 Bgm 30.61 Mn 20.79 Mn - -11.82%

Historic Data

Download Data
DateValue
Sep 30, 2025 -11.82%
Mar 31, 2025 -13.74%
Sep 30, 2024 -2.11%
Sep 30, 2023 -22.18%
Sep 30, 2022 46.07%